Competitor Product definition

Competitor Product shall have the meaning set forth in Section 18.

Split View

AI-Powered Contracts

Draft, Review & Redline at the Speed of AI

Get StartedSchedule a Demo

Competitor Product means any pharmaceutical product containing buprenorphine for the treatment of the Initial Indication that entails continuous delivery for more than 10 days. “Dossier” means the complete pharmaceutical registration dossier prepared by Titan in E.U. format suitable to obtain the Marketing Authorization(s) (as defined below) for the Product (as defined below) for the Initial Indication (as defined below) in the Territory (as defined below), including all scientific and technical data and documents regarding the Product for the Initial Indication, in all its available strengths and presentations; “DPT Agreement” means the Manufacturing Agreement by and between DPT Laboratories, Ltd. and Titan Pharmaceuticals, Inc. dated August 2, 2013; “Initial Indication” means the use of the Product for the treatment of opiate or opioid addiction. “Key Country” shall mean any of the following: United Kingdom, Italy, Germany, or France; “Marketing Authorization” means the required national registration and pricing approval for the Product for the Initial Indication issued by the relevant regulatory authorities in the Territory; “Net Sales” means the gross Ex-factory sales amount invoiced by Molteni and/or its appointed distributor(s) within the Territory for the sale of the Product, reduced by: (i) discounts actually granted and returns credited; (ii) payments by any distributor to Molteni other than for the final sale of the Product to the end customer; and (iii) sales taxes, value-added taxes, excise taxes, tariffs and duties, including government compulsory deduction on sales (i.e. payback mechanism) and other rebates and taxes directly related to the sale of the Product in the Territory, up to a limit of 20% (twenty percent) of the gross Ex-factory sales amount;

Competitor Product has the meaning set forth in Section 10.2(a)(iv).

Examples of Competitor Product in a sentence

• For the five year period following issuance of the MAA, Molteni shall not market any Competitor Product in the Territory.

• For the sake of clarity, Titan shall not market or offer for sale, directly or indirectly, any Competitor Product in the Territory during the term of this Agreement.

• Notwithstanding the foregoing, the Royalty-Paying Party shall be entitled to reduce the amount of royalties payable to the other Party pursuant to Section 9.2.1 if, with respect to a given country, [**] in the case of [**] of the [**] which [**] (a "Competitor Product").

• During the Agreement Term, Titan will not, and will not enter in to any additional arrangements to, Promote, market, commercialize, dispose of, or sell, directly or indirectly, or permit its Affiliates to Promote, market, commercialize, dispose of, or sell any Competitor Product in the Territory, or acquire, or permit its Affiliates to acquire, directly or indirectly any rights or interest in or to any Competitor Product that is being Promoted, marketed or sold in the Territory.

• For a period of seven (7) years after the Closing Date (the "Non-Compete Period"), none of Seller or its Affiliates shall (a) research, develop, market, distribute or manufacture any other pharmaceutical product containing the API for sale within the Territory (collectively, a "Competitor Product") or (b) agree to research, develop, market, sell, distribute or manufacture a Competitor Product for any other Person for sale of such Competing Product by such other Person in the Territory.

More Definitions of Competitor Product

Competitor Product means any product that [***].

Competitor Product means any dressing intended for the treatment of wound management which is comprised of open conduits polymeric matrix (e.g., polyurethane) and a hydrophilic polymer (e.g., hyaluronic acid) or based on the technology described in the Patent or that the Product is the predicate device used to approve a 510K or CE m▇▇▇ of such Competitor Product.

Competitor Product means any pharmaceutical product containing buprenorphine for the treatment of the Initial Indication that entails continuous delivery for more than 10 days.

Competitor Product shall have the meaning set forth in Section 18. 1.16 “Compliance Certification” shall have the meaning set forth in Section 3.7.1. 1.17 “Components” means those Assigned Components, Generic Components, and Consigned Components. 1.18 “Consigned Components” means those components that are provided by or on behalf of Company, to Jabil, at Company’s expense for assembly into Products, including those Components or materials specifically identified in writing by Company as “consigned.” 1.19 “Defect” shall have the meaning set forth in Section 5.4. 1.20 “Deliverable” shall mean an item specified as a deliverable in a SOW corresponding to Additional Services provided by Jabil. 1.21 “EDI” shall mean electronic data interchange. 1.22 “Effective Date” shall mean the date upon which the terms and conditions of this Agreement shall become effective by and between the Parties. The Parties have agreed that the Effective Date of this Agreement shall be the late date of execution on the signature page to this Agreement. 1.23 “Encumbrance” means any encumbrance, lien, charge, hypothecation, pledge, mortgage, title retention agreement, security interest of any nature, adverse claim, exception, right of set-off, any matter capable of registration against title, option, right of pre-emption, privilege or any contract to create any of the foregoing. Portions of this Exhibit were omitted and have been filed separately with the Secretary of the Commission pursuant to the Company’s application requesting confidential treatment under Rule 24b-2 of the Exchange Act — [*] denotes omissions.

Competitor Product means any product for the treatment of asthma or any other product that is targeted for an indication covered by any Product.

Competitor Product means any pharmaceutical product containing buprenorphine for the treatment of the Initial Indication that entails continuous delivery for more than ten (10) days, other than a Final Product introduced in the Territory in accordance with the terms of this Agreement.